We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
158 hedge funds and large institutions have $1.48B invested in Revance Therapeutics, Inc. in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 43
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 161 → 158 (-3)
5% less capital invested
Capital invested by funds: $1.56B → $1.48B (-$85.7M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
32% less call options, than puts
Call options by funds: $7.13M | Put options by funds: $10.4M
Holders
158
Holders Change
-3
Holders Change %
-1.86%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
56
Reduced
43
Closed
19
Calls
$7.13M
Puts
$10.4M
Net Calls
-$3.31M
Net Calls Change
+$1.24M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21.5M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$16.8M |
| 3 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$9.42M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$7.91M |
| 5 |
BAMCO Inc
New York
|
+$7.38M |
